Uni-Bio Science Group

Uni-Bio Science Group EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Uni-Bio Science Group (690.HK) as of Oct 16, 2026 is 91.84 M HKD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 78.30 M HKD — a change of 17.29% (higher).

EBITDA

91.84 MHKD

YoY

17.29%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Uni-Bio Science Group is 2024 91.84 M HKD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Uni-Bio Science Group was 2023 78.30 M HKD. It decreases by 17.29% higher compared to the previous year.

The Uni-Bio Science Group EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
-73.42 M HKD
Jan 1, 2018
-113.56 M HKD
Jan 1, 2019
-46.81 M HKD
Jan 1, 2020
-28.21 M HKD
Jan 1, 2021
3.56 M HKD
Jan 1, 2022
49.95 M HKD
Jan 1, 2023
78.30 M HKD
Jan 1, 2024
91.84 M HKD
The Uni-Bio Science Group EBITDA history
YEAREBITDAYoY
91.84 MHKD+17.29%
78.30 MHKD+56.75%
49.95 MHKD+1,303.15%
3.56 MHKD-112.62%
-28.21 MHKD-39.74%
-46.81 MHKD-58.78%
-113.56 MHKD+54.68%
-73.42 MHKD+42.64%
-51.47 MHKD-10.81%
-57.71 MHKD+27.13%
-45.40 MHKD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Uni-Bio Science Group Stock analysis

What does Uni-Bio Science Group do? Uni-Bio Science Group Ltd, listed on the Hong Kong Stock Exchange under ticker 690.HK with ISIN KYG9198H1406, operates in the Health Care sector within the Biotechnology industry. The company, which completed its IPO on November 12, 2001, employs 340 full-time staff. Uni-Bio Science Group functions through four business segments. The In-house Chemical Pharmaceutical Products segment focuses on manufacturing and selling proprietary chemical pharmaceutical products, including the product named Pinapu. The In-house Biological Pharmaceutical Products segment handles the production and distribution of biological pharmaceutical products such as GeneTime and GeneSoft. The In-house Biological Pipeline segment is dedicated to advancing the industrialization of its biological pipeline, featuring products like Uni-E4 and Uni-PTH. The Third-party Pharmaceutical Products segment manages the sales of pharmaceutical products from external suppliers. The company's headquarters location is not publicly specified, and its official website is www.uni-bioscience.com. Uni-Bio Science Group's business model integrates in-house development with third-party product distribution, targeting both chemical and biological pharmaceutical markets. The company's operational structure reflects a diversified approach to pharmaceutical research, development, and commercialization, though specific details about its research pipeline, market reach, or financial performance are not provided in the available information. Uni-Bio Science Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Uni-Bio Science Group stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Uni-Bio Science Group is 91.84 M HKD in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Uni-Bio Science Group changed from 78.30 M HKD to 91.84 M HKD, representing a 17.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Uni-Bio Science Group since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s HKD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Uni-Bio Science Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Uni-Bio Science Group

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Uni-Bio Science Group